Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "NTAGI"

26 News Found

Mandaviya chairs high level meeting to review COVID-19 status
Policy | June 24, 2022

Mandaviya chairs high level meeting to review COVID-19 status

The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases


Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India
News | March 24, 2022

Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India

This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system


Govt to deploy Truenat platform for TB screening across India
News | March 19, 2022

Govt to deploy Truenat platform for TB screening across India

It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour


Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
News | March 16, 2022

Bharat Biotech and Biofabri to develop and distribute novel TB vaccine

MTBVAC is a global public-private project that will be a milestone in the field of vaccinology


AbbVie and Scripps Research plan to develop anti-viral for Covid-19
News | March 15, 2022

AbbVie and Scripps Research plan to develop anti-viral for Covid-19

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Mylab’s CoviSelf can detect Omicron: Study
Equipment | January 10, 2022

Mylab’s CoviSelf can detect Omicron: Study

Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully


Moderna Covid-19 boosters after five-month interval: U.S. FDA
News | January 08, 2022

Moderna Covid-19 boosters after five-month interval: U.S. FDA

Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older


Curran Biotech’s develops nano coating to combat Covid-19 variants
Healthcare | December 21, 2021

Curran Biotech’s develops nano coating to combat Covid-19 variants

The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters


Study shows Glaxo-Vir drug works against Omicron mutations
News | December 07, 2021

Study shows Glaxo-Vir drug works against Omicron mutations

Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19